By group, procedural success and freedom from LVOT obstruction (LVOT mean gradient > 50 mm Hg), the primary efficacy endpoint ...

Q I am 66 years old and an avid cyclist. Last winter, after we went for a long ride, I suddenly felt lightheaded and then ...

I am 66 years old and an avid cyclist. Last winter, after we went for a long ride, I suddenly felt lightheaded and then fainted. My doctor ordered a series of heart scans that found slight mitral ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery ...

New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, ...

Patients in whom tricuspid valve anatomy is not evaluable by TTE or TEE * Untreatable hypersensitivity or contraindication to any of the following: all antiplatelets, all anticoagulants, nitinol ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

The mitral valve replacement system is launching into markets already ... That outlook assumes a mid-year label expansion supported by data in asymptomatic severe aortic stenosis patients.

even after successful valve surgery. This is according to a new study, "Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery" from ...

The condition is more common in women and younger patients with valve disorder and can, in the worst case, lead to sudden cardiac arrest. Mitral annular disjunction, MAD, is a heart abnormality in ...